Stock screenerAll disclosures →
EDGAR →
GLUE
Conviction 36HealthcareScan · Mon, Aug 10, 2026GLUE$15.81-0.44%
ResistanceSupportVol 14Insider sell2
2
3
2
2
Vol MA14 1.91M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price15.81
Change-0.44%
Gap-0.50%
Rel volume1.49×
Avg volume1.64M
Avg $ vol31.04M
SMA 2020.56
SMA 5020.39
SMA 20018.33
Price vs 50-22.45%
Price vs 200-13.72%
MA stackmixed
50/200 cross—
Supertrenddown · 20.57
RSI (14)31
MACD hist-0.79
MACD cross—
Stoch %K / %D10 / 10
ADX (14)33
+DI / −DI11 / 28
RSI divergence—
MACD divergence—
ATR %+10.09%
ADR %6.66%
52w high25.31
52w low4.19
From 52w high-37.53%
Above 52w low+277.33%
New 52w highNo
SqueezeOff
Bollinger width68.26%
%B0.16
Donchian pos9.14%
Donchian high25.16
Donchian low14.87
AVWAP (52w high)19.66
vs AVWAP high-19.60%
AVWAP (52w low)16.41
vs AVWAP low-3.63%
OBV trendDown
Chaikin MF (20)0.12
Today vs 20d1.49×
Avg vol (14d)1.91M
Avg vol (20d)1.64M
Avg $ vol (20d)31.04M
Market cap—
RS 3m (vs SPY)-25.54%
RS 6m (vs SPY)-30.09%
RS line new highNo
Trend template4/8
Technical rank15.1
1 week+2.80%
1 month-31.38%
3 months-18.46%
6 months-19.13%
1 year+273.76%
YTD+3.27%
P/E-35.11
P/B2.78
P/S10.96
P/FCF-49.31
EPS-2.96
Div yield—
ROE-7.93%
ROA-5.59%
Debt/Eq—
Current10.58
EV/EBITDA—
Gross margin—
Net margin-31.23%
Rev growth63.54%
EPS growth46.87%
Price target29.50
Target upside85.59%
Analyst ratingBuy
Institutional107.96%
Ent. value1.27B
Revenue8.97M
Net income-43.4M
Gross profit—
Free cash flow-27.5M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out84.48M
Employees161
ListedThu, Jun 24, 2021
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction36 / 100
Pattern quality—
Tech rank15.1 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance25.19
Support14.98
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in GLUE
No recent disclosed trades by Congress in GLUE. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in GLUE · 2 buys · 8 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Warmuth Markus President & CEO · Common Stock · 2026-07-16 | Sell | 9.5K | $220K | 2026-07-16 | 2026-07-17 |
Champoux Jennifer Chief Operating Officer · Stock Option (Right to Buy) · 2026-07-15 | Exercise | 4.35K | — | 2026-07-15 | 2026-07-16 |
Champoux Jennifer Chief Operating Officer · Common Stock · 2026-07-15 | Exercise | 4.35K | $17K | 2026-07-15 | 2026-07-16 |
Champoux Jennifer Chief Operating Officer · Common Stock · 2026-07-15 | Sell | 4.35K | $102K | 2026-07-15 | 2026-07-16 |
Townson Sharon Chief Scientific Officer · Common Stock · 2026-07-06 | Sell | 5.6K | $130K | 2026-07-06 | 2026-07-07 |
Townson Sharon Chief Scientific Officer · Stock Option (Right to Buy) · 2026-07-06 | Exercise | 6K | — | 2026-07-06 | 2026-07-07 |
Townson Sharon Chief Scientific Officer · Common Stock · 2026-07-06 | Exercise | 6K | $37K | 2026-07-06 | 2026-07-07 |
Townson Sharon Chief Scientific Officer · Common Stock · 2026-07-06 | Sell | 400 | $10K | 2026-07-06 | 2026-07-07 |
Manning Anthony M. Director · Common Stock · 2026-06-29 | Sell | 10K | $231K | 2026-06-29 | 2026-06-30 |
Manning Anthony M. Director · Stock Option (Right to Buy) · 2026-06-29 | Exercise | 10K | — | 2026-06-29 | 2026-06-30 |
SEC filings
EDGAR filings in GLUE · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.